BIOMAT Database Logo BIOMAT Database Logo

Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis. 1991

F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
Medical Oncology Division, Policlinico Hospital, Perugia, Italy.

In a double-blind crossover antiemetic study in cisplatin-treated cancer patients, metoclopramide 4 mg/kg as a single intravenous dose (regimen A) was compared with 3 mg/kg in two doses (regimen B). In both regimens, metoclopramide was combined with dexamethasone and diphenhydramine. 65 consecutive, chemotherapy-naïve inpatients (45 males and 20 females) treated with high doses (at least 50 mg/m2) of cisplatin entered the study and 54 completed both treatments. Complete protection from vomiting and nausea, mean number of emetic episodes, mean maximum intensity of nausea and mean duration of emesis or nausea were similar with the two antiemetic regimens. 23 patients (43%) did not express a treatment preference, while 16 (30%) preferred regimen B and 15 (28%) preferred regimen A. Side-effects were similar with the two metoclopramide schedules. A combined antiemetic regimen of a single high dose of metoclopramide (4 mg/kg) can preserve efficacy and tolerability and thus should be preferred.

UI MeSH Term Description Entries
D008297 Male Males
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004155 Diphenhydramine A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. Benhydramin,Diphenylhydramin,2-Diphenylmethoxy-N,N-dimethylethylamine,Allerdryl,Benadryl,Benylin,Benzhydramine,Dimedrol,Diphenhydramine Citrate,Diphenhydramine Citrate (1:1),Diphenhydramine Hydrochloride,Diphenylhydramine,Dormin,Citrate, Diphenhydramine,Hydrochloride, Diphenhydramine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis.
January 1996, Cancer chemotherapy and pharmacology,
F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis.
January 1991, Cancer chemotherapy and pharmacology,
F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin.
November 1988, Cancer,
F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
A double-blind randomized cross-over comparison of high-dose prochlorperazine with high-dose metoclopramide for cisplatin-induced emesis.
January 1991, Oncology,
F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
February 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.
June 2015, Annals of oncology : official journal of the European Society for Medical Oncology,
F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis.
May 1987, Pharmacology & toxicology,
F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesis.
January 1987, Oncology,
F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo.
December 1989, American journal of clinical oncology,
F Roila, and C Basurto, and S Bracarda, and M Sassi, and M Lupattelli, and M Picciafuoco, and E Boschetti, and M Tonato, and A Del Favero
Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
January 1984, Clinical pharmacy,
Copied contents to your clipboard!